Can ginkgo biloba combat diseases?

Puerto Rico Health Sciences Journal

Volumn 28, Issue 1, 2009, Pages 66-74

  Pérez, Carmen M ^a  

^a UNIVERSIDAD DEL TURABO   (Puerto Rico)

Author keywords

Dietary supplements; Flavonoids; Herbal medicine

Indexed keywords

DIET SUPPLEMENTATION; GINKGO BILOBA; HUMAN; PHYTOTHERAPY; REVIEW;

DIETARY SUPPLEMENTS; GINKGO BILOBA; HUMANS; PHYTOTHERAPY;

EID: 70350005019     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. National Institutes of Health. Clinical Trials. Available at: URL: http://clinicaltrials.gov/ct/show/NCT00010803?order=1.
2. Position of the American Dietetic Association: Food fortification and dietary supplements. J Am Diet Assoc 2001;101:115-125.
3. Springer RJ. Can nutritional supplements benefit ocular health? Rev Ophthalmology 2004;11:57-60.
4. United States Food and Drug Administration. Dietary supplement health and education act of 1994. Center for food safety and applied nutrition. Available at
5. Hellmich N. A botanical debate infuses herb industry. USA Today. 2003.
6. Gunther S, Patterson, RE, Kristal, AR, Stratton, KL, et al. Demographic and health- related correlates of herbal and specialty supplement use. J Am Diet Assoc 2004;104:27-34.
7. Insel P, Turner RE, Ross D. Nutrition. Jones and Bartlett Publishers, Inc., 2004;76:82-83.
8. Burns RD, Schiller MR, Merrick MA, Wolf KN. Intercollegiate student athlete use of nutritional supplements and the role of athletic trainers and dietitians in nutrition counseling. J Am Diet Assoc 2004;104:246-249.
9. Hodges PJ, Kam PCA. The peri-operative implications of herbal medicines. Anaesthesia 2002;57:889-899.
10. Li W, Fitzloff JF. HPLC determination of flavonoids and terpene lactones in commercial Ginkgo biloba products. Journal of Liquid Chromatography and Related Technologies 2002;25:2501-2514.
11. Sierpina VS, Wollschlaeger B, Blumenthal M. Ginkgo biloba. Am Fam Physician 2003;68:923-926.
12. Top-Selling Medicinal Herbs in the US, 1998-2002. World Almanac and Book Facts, 2004: p. 97-105.
13. Smith JV, Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol 2004;64:465-472.
14. Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba a case report and systematic review of the literature. J Gen Intern Med 2005;20:657-661.
15. Gold PE, Cahill L, Wenk GL. Ginkgo Biloba: A cognitive enhancer? Psychol Sci Publ Interest 2002;3:2-11.
16. Mattes RD, Pawlik MK.Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults. Hum Psychopharmacol Clin Exp 2004;19:81-90.
17. Freeman L. Mosby's Complementary and Alternative Medicine. A Research-Based Approach. Mosby, Inc., 2004: p. 455-460.
18. Schaffer DM, Gordon NP, Jensen CD, Avins AL. Nonvitamin, nonmineral supplement use over a 12-month period by adult members of a large health maintenance organization. J Am Diet Assoc 2003;103:1500-1505.
19. Zimmermann M, Colciaghi F, Cattabeni F, Di Luca M. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzheimer's disease. Cell Mol Biol 2002;48:613-623.
20. US General Accounting office. Report to chairman, special committee on aging, US senate. Health products for seniors. "Anti-Aging" products for physical and economic harm. 2001;9:16, 30.
21. American Botanical Council. Ginkgo biloba leaf extract. Herbalgram. org. Available at
22. Mckenna DJ, Jones K, Hughes K. Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 2001;7:70-90. (Pubitemid 32822186)
23. Son Y. Effects of nitrogen fertilization on foliar nutrient dynamics in ginkgo seedlings. J Plant Nutr 2002;25:93-102.
24. Smolinske SC. Dietary supplement-drug interactions. JAMWA 1999;54:191-192,195.
25. Bratman S, Girman AM. Mosby's handbook of herbs and supplements and their therapeutic Uses. Mosby, Inc., 2003: p. 593-601.
26. Oh SM, Chung KH. Estrogenic activities of Ginkgo biloba extracts. Life Sciences 2004;74:1325-1335.
27. Satoh H, Nishida S. Electropharmacological actions of Ginkgo biloba extract on vascular smooth and heart muscles. Clin Chim Acta 2004;342:13-22.
28. Van Beek TA. Chemical analysis of Ginkgo biloba leaves and extracts. J Chromatogr A 2002;967:21-55.
29. Mantle D, Wilkins RM, Gok MA. Comparison of antioxidant activity in commercial Ginkgo biloba preparations. J Altern Complement Med 2003;9:625-629.
30. ADIS R&D Profile. Egb 761 Ginkor biloba extract, Ginkor. Drugs in R&D 2003;4:188-193.
31. Gulec M, Mustafa I, Ramazan Y, Huseying O, et al. The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialhedehyde, and nitric oxide in cisplatin-induced nephrotoxicity. Toxicol Ind Health 2006;22:125-130.
32. Liu S-Q, Yu J-P, Chen H-L, Luo H-S, et al. Therapeutic effects and molecular mechanisms of ginkgo biloba extract on liver fibrosis in rats. Am J Chin Med 2006;34:99-114.
33. Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2002;CD003120.
34. Stevinson EE. Ginkgo biloba may help tinnitus but needs further investigation. BMJ 2003;327:630-633.
35. J.-Gertz, H, Kiefer M. Review about Ginkgo biloba special extract Egb 761 (Ginkgo). Curr Pharm Design 2004;10:261-264.
36. Bartlett H, Eperjesi F. Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. Ophthal Physiol Opt 2005;25:179-194.
37. Le Bars PL. Magnitude of effect and special approach to Ginkgo biloba Extract Egb 761® in cognitive disorders. Pharmacopsychiatry 2003;36:44-49.
38. Mahady GB. Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature. J Cardiovasc Nurs 2002;16:21-32.
39. Muir AH, Robb R, McLaren M, Daly F, et al. The use of Ginkgo biloba in Raynaud's disease: a doubleblind placebo-controlled trial. Vascular Medicine 2002;7:265-267.
40. Mahady GB. Ginkgo Biloba: A Review of Quality, Safety, and Efficacy. Nutr Clin Care 2001;4:140-147.
41. Doraiswamy PM. Non- cholinergic strategies for treating and preventing Alzheimer's Disease. CNS Drugs 2002;16:811-824.
42. Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, et al. Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract Egb[Sup®] in Alzheimer's Disease. Neuropsychobiology 2002;45:19-27.
43. Hodes RJ. Statement on Alzheimer's disease to senate. Appropriations committee, subcommittee on labor, health and human services and education. National Institute of Aging. Available at: URL: www.nia.nih.gov/AboutNIA/ BudgetRequests/AD2001April3.htm.
44. National Institutes of Health. Office of Dietary Supplements. Available at: URL: http://dietary-supplements.info.nih.gov/.
45. Cala S, Baumgarther J, Crismon ML. A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy 2003;23:222-230.
46. Fetrow CW, Avila JR. Professional's Handbook of Complementary & Alternative Medicines. Lippincott Williams & Wilkins, 2004: p. 358-365.
47. Guttman C, Quaranta L. Visual field damage may improve with Ginkgo biloba. Ophthalmol Times 2001;26:18.
48. Ritch R. How Ginkgo biloba extract has value in medicinal use. Ophthalmol Times 2000;25:14-15.
49. Dailey RK, Neale AV, Northrup J, West P, et al. Herbal product use and menopause symptom relief in primary care patients; A Metro-Net study. J Womens Health 2003;12:633-641.
50. Oh SM, Chung KH. Antiestrogenic activities of Ginkgo biloba extracts. J Steroid Biochem Mol Biol 2006;100:167-176.
51. Hartley DE, Heinze L, Elsabagh S, File SE. Effects on cognition and mood in postmenopausal women of 1- week treatment with Ginkgo biloba. Pharmacol Biochem Behav 2003;75;711-720.
52. Bressler R. Herb-drug interactions, Interactions between Ginkgo biloba and prescription medications. Geriatrics 2005;60:30-33. (Pubitemid 40529448)